Jove
Visualize
Contact Us

Related Experiment Videos

Palliative care in patients with multiple sclerosis.

A B Ben-Zacharia1, F D Lublin

  • 1Nurse Practitioner, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, The Mount Sinai Medical Center, New York, New York 10029, USA. aliza.ben-zacharia@mssm.edu

Neurologic Clinics
|February 21, 2002
PubMed
Summary

Multiple Sclerosis (MS) is a CNS disease with unpredictable courses. Palliative care and disease-modifying treatments improve quality of life for MS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study.

European journal of neurology·2019
Same author

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics.

Multiple sclerosis and related disorders·2015
Same author

Clinical course in multiple sclerosis patients presenting with a history of progressive disease.

Multiple sclerosis and related disorders·2015
Same author

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.

Neurology·2011
Same author

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

Multiple sclerosis (Houndmills, Basingstoke, England)·2010
Same author

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.

Neurology·2009
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS).
  • MS is characterized by unpredictable neurological function decline and disability.
  • Predictive factors for disease course are crucial for management.

Purpose of the Study:

  • To highlight the role of palliative care in managing MS symptoms and improving quality of life.
  • To discuss the impact of disease-modifying agents on MS treatment.
  • To emphasize the importance of symptomatic relief and patient counseling.

Main Methods:

  • Review of current treatment strategies for Multiple Sclerosis.
  • Analysis of the components of palliative care in MS.
  • Examination of the effects of disease-modifying therapies.

Related Experiment Videos

Main Results:

  • Palliative care focuses on symptom management, psychosocial support, and rehabilitation to enhance quality of life.
  • Disease-modifying agents like interferon beta, glatiramer acetate, and mitoxantrone are primary treatments.
  • Symptomatic relief and patient counseling significantly impact the quality of life for individuals with MS.

Conclusions:

  • Effective management of Multiple Sclerosis involves a combination of disease-modifying treatments and comprehensive palliative care.
  • Addressing symptoms and providing psychosocial support are vital for improving patient outcomes.
  • Understanding predictive factors can aid in personalized MS management strategies.